Daclizumab as Useful Treatment in Refractory Acute GVHD: A Paediatric Experience

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2008.331
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Mesenchymal Stem Cell as Salvage Treatment for Refractory Chronic GVHD

Bone Marrow Transplantation
TransplantationHematology
2010English

Carfilzomib for Treatment of Refractory Chronic Gvhd: A Chronic GVHD Consortium Pilot Trial

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Updated Experience With Inolimomab as Treatment for Corticosteroid-Refractory Acute Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

MRD Response in a Refractory Paediatric T-All Patient Through Anti-Programmed Cell Death 1 (PD-1) Ab Treatment Associated With Induction of Fatal GvHD

Bone Marrow Transplantation
TransplantationHematology
2017English

Salvage Treatment for Refractory or Relapsed Acute Myeloid Leukemia: A 10-Year Single-Center Experience

Clinics
Medicine
2020English

Safety and Effectiveness of Vedolizumab in Patients With Steroid-Refractory GI Acute GvHD: A Retrospective Record Review

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

State-Of-The-Art Acute and Chronic GVHD Treatment

International Journal of Hematology
Hematology
2015English

Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease With Daclizumab and Etanercept

Bone Marrow Transplantation
TransplantationHematology
2005English

Etanercept as Treatment of Steroid-Refractory Acute Graft Versus Host Disease in Pediatric Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy